Results 161 to 170 of about 28,723 (210)
Fatal retroperitoneal hemorrhage following enoxaparin administration in a patient with autoimmune encephalitis: a case report. [PDF]
EncephalitisJeon JY, Yu B.
europepmc +1 more source
Reactions Weekly, 2021 The development of low-molecular and ultra-low-molecular weight heparins has changed anticoagulation treatment options. Enoxaparin is a low-molecular weight heparin (LMWH), which works on Factor Xa and is indicated for both the prevention and treatment ...
Padayachee, N. +2 more
core +3 more sources
Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
Thrombosis Research, 2021 International audiencePurposeIn intensive-care unit (ICU) patients, pathophysiological changes may affect thepharmacokinetics of enoxaparin and result in underdosing.
Sophie Susen +2 more
exaly +2 more sources
Population Pharmacokinetics of Enoxaparin During the Antenatal Period
Circulation, 2013 Background—The optimal dosing strategy of low-molecular-weight heparins for the treatment of antenatal venous thromboembolism is not known. The physiological changes associated with pregnancy alter the pharmacokinetic profile of low-molecular-weight ...
Roopen Arya +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical application of enoxaparin
Expert Review of Cardiovascular Therapy, 2004Low-molecular-weight heparins have several important advantages over unfractionated heparin (UFH). Due to a longer plasma half life together with high bioavailability and a linear dose-response relationship, the drugs can be safely and effectively administered in the hospital or ambulatory settings without the need to monitor the anticoagulant effect ...
openaire +2 more sources